Eledon Pharmaceuticals, Inc. Increase Decrease In Operating Lease Liability
Eledon Pharmaceuticals, Inc. (ELDN) reported Increase Decrease In Operating Lease Liability of -$174.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-13
- Eledon Pharmaceuticals, Inc. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$88.00K.
- Eledon Pharmaceuticals, Inc. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$86.00K.
- Eledon Pharmaceuticals, Inc. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$81.00K.
- Eledon Pharmaceuticals, Inc. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$81.00K.
- Eledon Pharmaceuticals, Inc. increase decrease in operating lease liability for fiscal 2025 was -$313.00K.
- Eledon Pharmaceuticals, Inc. increase decrease in operating lease liability for fiscal 2024 was -$339.00K.
- Eledon Pharmaceuticals, Inc. increase decrease in operating lease liability for fiscal 2023 was -$363.00K.
- Eledon Pharmaceuticals, Inc. increase decrease in operating lease liability for fiscal 2022 was -$367.00K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$88.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$174.00K 10-Q · filed 2026-08-13 | -$255.00K derived: sum of 3 quarters · filed 2026-08-13 | -$336.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | -$86.00K 10-Q · filed 2026-05-13 | -$167.00K derived: sum of 2 quarters · filed 2026-05-13 | -$248.00K derived: sum of 3 quarters · filed 2026-05-13 | -$325.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | -$81.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | -$162.00K derived: sum of 2 quarters · filed 2026-03-19 | -$239.00K derived: sum of 3 quarters · filed 2026-08-13 | -$313.00K 10-K · filed 2026-03-19 |
| 2025-09-30 | -$81.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$158.00K derived: sum of 2 quarters · filed 2026-08-13 | -$232.00K 10-Q · filed 2025-11-14 | -$322.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | -$77.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$151.00K 10-Q · filed 2026-08-13 | -$241.00K derived: sum of 3 quarters · filed 2026-08-13 | -$324.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | -$74.00K 10-Q · filed 2026-05-13 | -$164.00K derived: sum of 2 quarters · filed 2026-05-13 | -$247.00K derived: sum of 3 quarters · filed 2026-05-13 | -$314.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | -$90.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | -$173.00K derived: sum of 2 quarters · filed 2026-03-19 | -$240.00K derived: sum of 3 quarters · filed 2026-03-19 | -$339.00K 10-K · filed 2026-03-19 |
| 2024-09-30 | -$83.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$150.00K derived: sum of 2 quarters · filed 2025-11-14 | -$249.00K 10-Q · filed 2025-11-14 | -$345.00K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | -$67.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2025-08-14 | -$166.00K 10-Q · filed 2025-08-14 | -$262.00K derived: sum of 3 quarters · filed 2025-08-14 | -$357.00K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$99.00K 10-Q/A · filed 2025-08-14 | -$195.00K derived: sum of 2 quarters · filed 2025-08-14 | -$290.00K derived: sum of 3 quarters · filed 2025-08-14 | -$384.00K derived: sum of 4 quarters · filed 2025-08-14 |
| 2023-12-31 | -$96.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-08-14 | -$191.00K derived: sum of 2 quarters · filed 2025-08-14 | -$285.00K derived: sum of 3 quarters · filed 2025-08-14 | -$363.00K 10-K/A · filed 2025-08-14 |
| 2023-09-30 | -$95.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$189.00K derived: sum of 2 quarters · filed 2024-11-12 | -$267.00K 10-Q · filed 2024-11-12 | -$360.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$94.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2024-08-19 | -$172.00K 10-Q · filed 2024-08-19 | -$265.00K derived: sum of 3 quarters · filed 2024-08-19 | -$356.00K derived: sum of 4 quarters · filed 2024-08-19 |
| 2023-03-31 | -$78.00K 10-Q/A · filed 2024-08-19 | -$171.00K derived: sum of 2 quarters · filed 2024-08-19 | -$262.00K derived: sum of 3 quarters · filed 2024-08-19 | -$354.00K derived: sum of 4 quarters · filed 2024-08-19 |
| 2022-12-31 | -$93.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-08-19 | -$184.00K derived: sum of 2 quarters · filed 2024-08-19 | -$276.00K derived: sum of 3 quarters · filed 2024-08-19 | -$367.00K 10-K/A · filed 2024-08-19 |
| 2022-09-30 | -$91.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$183.00K derived: sum of 2 quarters · filed 2023-11-09 | -$274.00K 10-Q · filed 2023-11-09 | -$334.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$92.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$183.00K 10-Q · filed 2023-08-10 | -$243.00K derived: sum of 3 quarters · filed 2023-08-10 | -$289.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$91.00K 10-Q · filed 2023-05-11 | -$151.00K derived: sum of 2 quarters · filed 2023-05-11 | -$197.00K derived: sum of 3 quarters · filed 2023-05-11 | -$244.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$60.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$106.00K derived: sum of 2 quarters · filed 2023-03-30 | -$153.00K derived: sum of 3 quarters · filed 2023-03-30 | -$200.00K 10-K · filed 2023-03-30 |
| 2021-09-30 | -$46.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$93.00K derived: sum of 2 quarters · filed 2022-11-14 | -$140.00K 10-Q · filed 2022-11-14 | -$187.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$47.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$94.00K 10-Q · filed 2022-08-11 | -$141.00K derived: sum of 3 quarters · filed 2022-08-11 | |
| 2021-03-31 | -$47.00K 10-Q · filed 2022-05-12 | -$94.00K derived: sum of 2 quarters · filed 2022-05-12 | ||
| 2020-12-31 | -$47.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | -$180.00K 10-K · filed 2022-03-24 | ||
| 2020-09-30 | -$133.00K 10-Q · filed 2021-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |